Mymetics is a biotechnology company focused on the development of innovative prophylactic vaccines for infectious and life-disabling diseases using its proprietary virosome-based technology. Their research targets a range of diseases including HIV-1/AIDS, malaria, respiratory syncytial virus (RSV), and chikungunya, aiming to provide protection against early transmission and infection.